Poster Competition
Elevating Excellence
Present Your PosterUCLA Jonsson Comprehensive Cancer Center would like to invite graduate students, postdoctoral researchers, and clinical fellows to submit an abstract to be considered for displaying poster at the Cancer Center's retreat. This is a great opportunity for students and fellows to share their cancer-focused research projects and network with colleagues. Prizes are awarded in each category.
Next Opportunity May 2025
Submit Your Abstract HereGuidelines for Poster Abstracts
The Guidelines for Poster Abstracts provide clear instructions to ensure consistency and professionalism in abstract submissions. Abstracts should adhere to a concise structure, limited to a maximum of 250 words, to effectively communicate the essence of the research. Formatted in Microsoft Word, the abstracts should be single-spaced, employing a legible size 12 Times New Roman font. By adhering to these guidelines, presenters can convey their research findings effectively, facilitating a comprehensive understanding amongst reviewers.
Previous Poster Awardees
2023 Awardees
A Proimmunotoxin Nanodrug Targeting non-Hodgkin Lymphoma with Brain Metastases
Statins as a novel anti-metastatic reagent in kidney cancer
Single-Cell Analysis in Lung Adenocarcinoma Implicates RNA Editing in Cancer Innate Immunity and Patient Prognosis
Strength of CAR signaling determines T cell versus ILC differentiation from pluripotent stem cells
Spatial mapping of mitochondrial networks and bioenergetics in lung cancer
Off-the-shelf third-party HSC-engineered iNKT cells for ameliorating GvHD while preserving GvL effect in the treatment of blood cancers
2022 Awardees
Engineering the in vitro organoid microenvironment for positive selection of human psc-derived, class i-null, antigen specific t cells
Immunoengineering an Exclusive Fuel Source to Enhance Tumor Infiltrating Lymphocyte
Development of Allogeneic HSC-Engineered iNKT Cells for Off-The-Shelf Cancer Immunotherapy
An Integrative Genomic Transcriptomic and Proteomic Investigation to Characterize Differences Between Isogenic Radioresistant Prostate Cancer Cell Lines
Chronic HIV infection generates dysfunctional antitumor responses and loss of tumor suppression in humanized mice
Chimeric orthogonal IL-9 receptor signaling promotes stemness and polyfunctionality for adoptive T cell therapy of cancer in human in vitro models